THROMBOCYTHEMIA, ESSENTIAL

Clinical trials for THROMBOCYTHEMIA, ESSENTIAL explained in plain language.

Never miss a new study

Get alerted when new THROMBOCYTHEMIA, ESSENTIAL trials appear

Sign up with your email to follow new studies for THROMBOCYTHEMIA, ESSENTIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

New hope for patients who Can't tolerate standard blood disorder treatment

Disease control Ongoing

This study is testing whether a daily oral medication called IMG-7289 can help control essential thrombocythemia, a condition where the body makes too many platelets. It's for patients who can't tolerate or don't respond to the standard treatment, hydroxyurea. Researchers will ch…

Matched conditions: THROMBOCYTHEMIA, ESSENTIAL

Phase: PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

THROMBOCYTHEMIA, ESSENTIAL

Get alerted when new THROMBOCYTHEMIA, ESSENTIAL trials appear

New hope for patients who Can't tolerate standard blood disorder treatment